Travis Manning 11/18/25 Travis Manning 11/18/25

11/16/25 SymbioCellTech has been awarded the 2025 Levine-Riggs Symposium Scientific Achievement Award for its work on Neo-Islets as a therapy for Type 1 Diabetes Mellitus.

Travis Manning 9/19/24 Travis Manning 9/19/24

SymbioCellTech’s Stem Cell-Enabled Therapy Could Offer a Functional Cure for Type 1 Diabetes Without Requiring Anti-Rejection Drugs

Travis Manning 9/17/24 Travis Manning 9/17/24

SymbioCellTech Joins Startup Health’s Type 1 Diabetes Moonshot Fellowship to Advance Groundbreaking Neo-Islet Therapy

SymbioCelllTech becomes a member of StartupHealth’s Type 1 Diabetes Moonshot Fellowship

Travis Manning 8/13/24 Travis Manning 8/13/24

NeoIslets: Innovation Challenge Winner at ADA Scientific Session

Travis Manning 6/24/24 Travis Manning 6/24/24

SymbioCellTech Wins ADA Innovation Challenge for Groundbreaking Diabetes Biotherapy

Travis Manning 6/23/24 Travis Manning 6/23/24

SymbioCellTech's CSO Anna Gooch, PhD, to Present on Neo-Islet™ Technology at ADA 84th Scientific Sessions

Travis Manning 10/23/23 Travis Manning 10/23/23

SymbioCellTech, LLC Honored as Runner-Up in Medical & Health Med Tech at the 2023 Innovation Awards

Travis Manning 9/6/23 Travis Manning 9/6/23

Novel Biotherapy for Type I Diabetes Presented at This Year’s American Diabetes Association Meeting

Travis Manning 8/24/23 Travis Manning 8/24/23

Novel Biotherapy for Type I Diabetes Presented at This Year’s American Diabetes Association Meeting

SymbioCellTech, LLC 10/28/21 SymbioCellTech, LLC 10/28/21

SymbioCellTech Demonstrates Preclinical Efficacy of Proprietary and Novel Human Neo-Islets™ Technology in STZ-Diabetic NOD-SCID Mice